Zdeněk Švagera

Dr. Zdeněk Švagera

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2003 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
JPJitka Psotová
Jitka Psotová
Milan KolarMilan Kolar
Milan Kolar
JSJaromír Soušek
Jaromír Soušek
ZŠZdeněk Švagera
Zdeněk Švagera
JVJaroslav Vičar
Jaroslav Vičar
JUJitka Ulrichová
Jitka Ulrichová

Verified
Journal Article
Open access
PDF file
NPNadežda Petejová
Nadežda Petejová
AMArnost Martinek
Arnost Martinek
JZJosef Zadrazil
Josef Zadrazil
MKMarcela Káňová
Marcela Káňová
VKViktor Klementa
Viktor Klementa
David StejskalDavid Stejskal
David Stejskal
Acute kidney injury is a common complication in critically ill patients with sepsis and/or septic shock. Further, some essential antimicrobial treatment drugs are themselves nephrotoxic. For this reason, timely diagnosis and adequate therapeutic management are paramount. Of potential acute kidney injury (AKI) biomarkers, non-protein-coding RNAs are a subject of ongoing research. This review covers the pathophysiology of vancomycin and gentamicin nephrotoxicity in particular, septic AKI and the microRNAs involved in the pathophysiology of both syndromes. PubMED, UptoDate, MEDLINE and Cochrane databases were searched, using the terms: biomarkers, acute kidney injury, antibiotic nephrotoxicity, sepsis, miRNA and nephrotoxicity. A comprehensive review describing pathophysiology and potential biomarkers of septic and toxic acute kidney injury in septic patients was conducted. In addition, five miRNAs: miR-15a-5p, miR-192-5p, miR-155-5p, miR-486-5p and miR-423-5p specific to septic and toxic acute kidney injury in septic patients, treated by nephrotoxic antibiotic agents (vancomycin and gentamicin) were identified. However, while these are at the stage of clinical testing, preclinical and clinical trials are needed before they can be considered useful biomarkers or therapeutic targets of AKI in the context of antibiotic nephrotoxicity or septic injury.

1 April 2016 in Journal of Chromatography A
Verified
Journal Article
Closed access
PHPetr Hušek
Petr Hušek
ZŠZdeněk Švagera
Zdeněk Švagera
DHDagmar Hanzlíková
Dagmar Hanzlíková
LŘLucie Řimnáčová
Lucie Řimnáčová
HZHelena Zahradníčková
Helena Zahradníčková
PŠPetr Šimek
Petr Šimek

23 September 2014 in Videosurgery and Other Miniinvasive Techniques
Verified
Journal Article
Open access
MBMarek Bužga
Marek Bužga
VZVladislava Zavadilová
Vladislava Zavadilová
PHPavol Holéczy
Pavol Holéczy
ZŠZdeněk Švagera
Zdeněk Švagera
PŠPavol Švorc
Pavol Švorc
PZPavel Zonča
Pavel Zonča
Introduction : Surgical intervention in obesity is today the most effective treatment method in high level obesity management. Bariatric interventions not only ensure body weight reduction, but may influence dietary habits. Aim: To assess changes in adipose hormones and dietary habits in...

1 February 2014 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
MBMarek Bužga
Marek Bužga
MEMachytka Evžen
Machytka Evžen
KPKlvaňa Pavel
Klvaňa Pavel
KTKupka Tomáš
Kupka Tomáš
ZVZavadilová Vladislava
Zavadilová Vladislava
ZŠZdeněk Švagera
Zdeněk Švagera
The prevalence of obesity continues to increase worldwide. Because obesity is associated with a number health-related problems as well as a shortened life span, treating obesity is an important clinical concern. Although various treatments are currently available, many are not efficacious in the long term. Therefore, additional medical treatment options for morbidly obese individuals must be explored. In this study, we examined the effects of the intragastric balloon MedSil® on anthropometric measures and hormones associated with lipid and energy metabolism.

15 November 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DZDavid Zeman
David Zeman
PKPavlína Kušnierová
Pavlína Kušnierová
ZŠZdeněk Švagera
Zdeněk Švagera
FVFrantišek Všianský
František Všianský
MBMonika Byrtusová
Monika Byrtusová
VBVladimír Bartoš
Vladimír Bartoš
We aimed to compare various methods for free light chain (fLC) quantitation in cerebrospinal fluid (CSF) and serum and to determine whether quantitative CSF measurements could reliably predict intrathecal fLC synthesis. In addition, we wished to determine the relationship between free kappa and free lambda light chain concentrations in CSF and serum in various disease groups. We analysed 166 paired CSF and serum samples by at least one of the following methods: turbidimetry (Freelite™, SPAPLUS), nephelometry (N Latex FLC™, BN ProSpec), and two different (commercially available and in-house developed) sandwich ELISAs. The results were compared with oligoclonal fLC detected by affinity-mediated immunoblotting after isoelectric focusing. Although the correlations between quantitative methods were good, both proportional and systematic differences were discerned. However, no major differences were observed in the prediction of positive oligoclonal fLC test. Surprisingly, CSF free kappa/free lambda light chain ratios were lower than those in serum in about 75% of samples with negative oligoclonal fLC test. In about a half of patients with multiple sclerosis and clinically isolated syndrome, profoundly increased free kappa/free lambda light chain ratios were found in the CSF. Our results show that using appropriate method-specific cut-offs, different methods of CSF fLC quantitation can be used for the prediction of intrathecal fLC synthesis. The reason for unexpectedly low free kappa/free lambda light chain ratios in normal CSFs remains to be elucidated. Whereas CSF free kappa light chain concentration is increased in most patients with multiple sclerosis and clinically isolated syndrome, CSF free lambda light chain values show large interindividual variability in these patients and should be investigated further for possible immunopathological and prognostic significance.